Ignite Creation Date:
2025-12-17 @ 2:50 PM
Ignite Modification Date:
2025-12-23 @ 4:53 PM
Study NCT ID:
NCT01029795
Status:
TERMINATED
Last Update Posted:
2011-12-02
First Post:
2009-12-09
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-02
Start Date Type:
None
Primary Completion Date:
2010-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-06
Completion Date Type:
ACTUAL
First Submit Date:
2009-12-09
First Submit QC Date:
None
Study First Post Date:
2009-12-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-09-15
Results First Submit QC Date:
None
Results First Post Date:
2011-10-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-03-11
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2011-11-29
Last Update Post Date:
2011-12-02
Last Update Post Date Type:
ESTIMATED